Is BCG Vaccination Against Tuberculosis Still Indicated?

References

• Gyselen A, Uydcbrouck M, Vermcire P. BCG-vaccinatie. In: Demcdts M, Gysclcn A, Van den Brando P, eds. Tuberculose, een blijvende uitdaging. Leuven; Apeldoorn: Garant 1992: 191–3.
   Google Scholar
• Aronson JD, Aronson CF, Taylor HC. A twentyyear appraisal of BCG vaccination in the control of tuberculosis. Arch Intern Med. 1958; 101: 881–93.
   Google Scholar
• Fine PEM. BCG vaccination against tuberculosis and leprosy. Dr Med Bull. 1988; 44: 691–703.
   Google Scholar
• Anonymous. BCG: bad news from India (editorial). Lancet.1980; i: 73–4.
   Google Scholar
• Styblo K. Is er in de tuberculosebestrijding nog plaats voor BCG-vaccinatie ? Ned Tijdschr Ceneeskd. 1984: 128; 1098–101.
   Google Scholar
• D’Arcy Hart P. Efficacy and applicability of mass BCG vaccination in tuberculosis control. Br Med J. 1967; 1:587–92.
   Google Scholar
• Stein SC, Aronson JD. The occurrcncc of pulmonary lesions in BCG-vaccinatcd and unvaccinated persons. Am Rev Tub Dis. 1953; 68: 695–712.
   Google Scholar
• Rosenthal SR. Loewinsohn E, Graham ML et al. BCG vaccination against tuberculosis in Chicago: a twenty-year study statistically analyzed. Pediatrics. 1961; 28: 622–41.
   Google Scholar
• Comstock GW, Webster RG. Tuberculosis studies in Muscogee County, Georgia. A twenty-year evaluation of BCG vaccination in a school population. Am Rev Resp Dis. 1969; 100: 839–45.
   Google Scholar
• Bettag OL, Kaluzny AA, Morse D. Radncr DB. BCG study al a state school for mentally retartcd. Dis Chest. 1969; 45: 503–7.
   Google Scholar
• Comstock GW, Livcsay VT, Woolpcrt SF. Evaluation of BCG vaccination among Puerto Rican children. Am J Publ Health. 1974; 64: 283–91.
   Google Scholar
• Comstock GW, Palmer CE. Long-term results of BCG vaccination in the southern United States Am Rev Resp Dis. 1966; 93: 171–83.
   Google Scholar
• Medical Research Council. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early life. Bull World Health Ore 1972; 46: 371–85.
   Google Scholar
• D’Arcy Hart P, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early life. Br Med J. 1977; 2: 2935.
   Google Scholar
• Frimodt-Moller J, Acharyulu GS, Parihasarathy R. Observations on the protective effect of BCG in a South Indian rural population. Ind J tub. 196840: 40–6.
   Google Scholar
• Tuberculosis Prevention Trial. Trial of BCG vaccines in South India for tuberculosis preventionfirst report. Bull Int Union Tuberc. 1980; 55–14 22.
   Google Scholar
• Citron KM. BCG vaccination agains tuberculosis: British and global perspectives, flr Med J 1993; 306: 222–3.
   Google Scholar
• Fine PM. The BCG story: lessons from the past and implications for the future. Rev Infect Dis 1989; 11: suppl 12: 353–9.
   Google Scholar
• Ten Dam HG. Research on BCG vaccination. Adv Tuberc Res. 1984; 21: 79–106.
   Google Scholar
• Dubos R. Acquired immunity to tuberculosis. Am Rev Resp Dis 1964; 90: 505–15.
   Google Scholar
• Curtis HM, Leek I, Bamford FN. Incidence of childhood tuberculosis after neonatal BCG vaccination. Lancer. 1984; i: 145–8.
   Google Scholar
• Schwocbel V, Hubert B, Grosset J. Impact of BCG on tuberculous meningitis in France in 1990. Lancet. 1992:340:611.
   Google Scholar
• Romanus V. Where do we stand with BCG ? Swedish experiences 12 years after the cessation of general BCG vaccination of newborns in 1975. Bull Int Union Tuberc. 1988; 63: 34–8.
   Google Scholar
• Citron KM. Control and prevention of tuberculosis in Britain. Br Med Bull. 1988; 44: 704–16.
   Google Scholar
• Palmer CE, LongMW. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Resp Dis. 1966; 94: 553–68.
   Google Scholar
• Wiegcshaus EH, Smith DW. Evaluation of the Protective Potency of New Tuberculosis Vaccines. Rev Infect Dis. 1989; 11, suppl 12: 484–90.
   Google Scholar
• Clemens JD, Chuong JJH, Fcinslein AR. The BCG controversy, a methodological and statistical reappraisal. MAM. 1983; 249: 2362–69.
   Google Scholar
• Styblo K. Overview and epidemiological assessment of the current global tuberculosis situation with an emphasis on control in developing countries. Rev Infect Dis. 1989; 11: suppl 12: 339–46.
   Google Scholar
• Pio A. Impact of present control methods on the problems of tuberculosis. Rev Infect Dis. 1989; 11: suppl 12: 360–5.
   Google Scholar
• Grosset J. Faut-il vacciner par le BCG ? Rev Pract (Med Gen). 1990; 100: 31–4.
   Google Scholar
• Styblo K, Meijer J. Impact of BCG vaccination programme in children and young adults on the tuberculosis problem. Tubercl. 1976; 57: 17–43.
   Google Scholar
• A joint statement by the ACIP and the advisory ACIP committee for elimination of tuberculosis. Use of BCG vaccines in the control of tuberculosis. JAMA. 1988; 260: 2983–91.
   Google Scholar
• Snider DE. Bacillc Calmette-Gudrin vaccinations and tuberculin skin tests. JAMA. 1985; 253: 34389.
   Google Scholar
• Comstock GW. Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis. 1988; 138:479–80.
   Google Scholar
• Anonymous. BCG vaccinations and pediatric HIV infection Rwanda, 1988–1990. MMWR 1991, 40: 833–6.
   Google Scholar
• Quinn TC. Interactions of the human immunodeficiency virus and tuberculosis and the implications for BCG vaccination. Rev Infect Dis. 1989; 11, suppl 12: 379–84.
   Google Scholar
• Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in Britain: an updated code of practice. Br Med J. 1990; 300: 995–9.
   Google Scholar
• Anonymous. Vaccinatic tegen tuberculosis. Folia Pharmaceutica.1991; 18: 17–8.
   Google Scholar
• Anonymous. Bettering BCG(editorial). Lxincet. 1992; 339: 462–3.
   Google Scholar
• PiSnninghaus JM, Fine PEM, Sterne JAC et al. Efficacy of BCG vaccine against leprosy and tuberculosis in Northern Malawi. Lancet. 1992; 339: 636–9.
   Google Scholar
• Hesse E. Prignot J. Vaccin BCG, VIH et SIDA. Louvain Medical. 1994; 113: 10–6.
   Google Scholar
• Watson JM. Tuberculosis in Britain today. Br Med J. 1993; 306: 221–2.
   Google Scholar
• Schandevyl W, Uydebrouck M, Gyselen A. Wordtook ons land bedreigd door multiresistente tuberculose ? Tijdschr Geneeskd. 1993; 49: 1379–87.
   Google Scholar
• Fischl MA, Uttamchandani RB, Daikos GL et al. An outbreak of tuberculosis caused by multipledrug-resistant tubercle bacilli among patients with HlV-infection. Ann Intern Med. 1992; 117: 17783.
   Google Scholar
• Fischl MA, Daikos GL, Uttamchandani RB el al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistani bacilli. Ann Intern Med. 1992, 117: 184–90.
   Google Scholar
• Pearson ML, Jereb JA, Frieden TR et al. Nosocomial transmission of mullidrug-resistani Mycobacterium tuberculosis. A risk lo patients and health care workers. Ann Intern Med. 1992; 117: 191–6.
   Google Scholar
• Dooley SW, Jarvis WR, Martone WJ, Snider DE. Multidrug-resistant tuberculosis (editorial). Ann Intern Med. 1992; 117: 257–9.
   Google Scholar
• Edlin BR, Tokars JI, Grieco MI I et al. An outbreak of muliidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992; 326: 1514–21.
   Google Scholar
• Frieden TR, Sterling T, Pablos-Mcndez A, Kilburn JP, Caulhen GM. Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993; 328: 521–6.
   Google Scholar
• Greenberg PD, Lax KG. Schechler CB. Tuberculosis in house staff; a decision analysis comparing the tuberculin screening strategy with the BCG vaccination. Am Rev Respir Dis. 1991; 143:490–5.
   Google Scholar
• Prignol J. Chemoprol’ylaxe. In: Demedls M, Gyselen A, Van den brande P, eds. Tuberculose, een blijvende uitdaging. Leuven, Apeldoorn: Garant 1992; 181–3.
   Google Scholar
• Neuleman MD. Use of BCG vaccines in shelters for the homeless. A decision analysis. Chest. 1993; 103: 1087–90.
   Google Scholar
• Kreukniel J. BCG vaccinatie. Ned Tijdschr Geneeskd. 1984; 128: 1104–05.
   Google Scholar